Aarhus University Seal / Aarhus Universitets segl

Páll Karlsson

Chronic Pain and Neuropathy Following Adjuvant Chemotherapy

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Chronic Pain and Neuropathy Following Adjuvant Chemotherapy. / Ventzel, Lise; Madsen, Caspar S; Karlsson, Páll; Tankisi, Hatice; Isak, Baris; Fuglsang-Frederiksen, Anders; Jensen, Anders B; Jensen, Anni R; Jensen, Troels S; Finnerup, Nanna B.

I: Pain Medicine, Bind 19, Nr. 9, 09.2018, s. 1813-1824.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{43cecb79fc474e67911be5d050cd746d,
title = "Chronic Pain and Neuropathy Following Adjuvant Chemotherapy",
abstract = "Objective: To determine symptoms and characteristics of chronic sensory neuropathy in patients treated with oxaliplatin and docetaxel, including patterns of somatosensory abnormalities, pain descriptors, and psychological functioning.Design: A retrospective cross-sectional study.Setting: A chronic pain research center.Subjects: Thirty-eight patients with chronic peripheral pain and/or dysesthesia following chemotherapy.Methods:  Sensory profiles, psychological functioning, and quality of life were assessed using standardized questionnaires. In addition, standardized quantitative sensory testing and nerve conduction studies were carried out.Results: The sensory profiles and clinical symptoms were very similar in the two groups. Pricking, numbness, and burning were common descriptors in both groups, and the predominant finding was sensory loss to A beta-mediated sensory modalities with decreased mechanical and vibration detection thresholds. A high frequency of abnormalities in thermal sensory limen and the presence of paradoxical heat sensation seem to be sensitive markers of small fiber loss. Both groups had mainly sensory, axonal large fiber or mixed fiber polyneuropathy, which tended to be most severe in the oxaliplatin group.Conclusions: Both oxaliplatin-induced and docetaxel-induced polyneuropathies represent a significant problem that affects the daily life of the patients. Our results, defining the somatosensory phenotype, can improve the understanding of the pathophysiological mechanisms useful for future studies in the tailored treatment of prevention of chemotherapy-induced peripheral neuropathy and pain.",
keywords = "Journal Article",
author = "Lise Ventzel and Madsen, {Caspar S} and P{\'a}ll Karlsson and Hatice Tankisi and Baris Isak and Anders Fuglsang-Frederiksen and Jensen, {Anders B} and Jensen, {Anni R} and Jensen, {Troels S} and Finnerup, {Nanna B}",
year = "2018",
month = sep,
doi = "10.1093/pm/pnx231",
language = "English",
volume = "19",
pages = "1813--1824",
journal = "Pain Medicine",
issn = "1526-2375",
publisher = "Oxford University Press",
number = "9",

}

RIS

TY - JOUR

T1 - Chronic Pain and Neuropathy Following Adjuvant Chemotherapy

AU - Ventzel, Lise

AU - Madsen, Caspar S

AU - Karlsson, Páll

AU - Tankisi, Hatice

AU - Isak, Baris

AU - Fuglsang-Frederiksen, Anders

AU - Jensen, Anders B

AU - Jensen, Anni R

AU - Jensen, Troels S

AU - Finnerup, Nanna B

PY - 2018/9

Y1 - 2018/9

N2 - Objective: To determine symptoms and characteristics of chronic sensory neuropathy in patients treated with oxaliplatin and docetaxel, including patterns of somatosensory abnormalities, pain descriptors, and psychological functioning.Design: A retrospective cross-sectional study.Setting: A chronic pain research center.Subjects: Thirty-eight patients with chronic peripheral pain and/or dysesthesia following chemotherapy.Methods:  Sensory profiles, psychological functioning, and quality of life were assessed using standardized questionnaires. In addition, standardized quantitative sensory testing and nerve conduction studies were carried out.Results: The sensory profiles and clinical symptoms were very similar in the two groups. Pricking, numbness, and burning were common descriptors in both groups, and the predominant finding was sensory loss to A beta-mediated sensory modalities with decreased mechanical and vibration detection thresholds. A high frequency of abnormalities in thermal sensory limen and the presence of paradoxical heat sensation seem to be sensitive markers of small fiber loss. Both groups had mainly sensory, axonal large fiber or mixed fiber polyneuropathy, which tended to be most severe in the oxaliplatin group.Conclusions: Both oxaliplatin-induced and docetaxel-induced polyneuropathies represent a significant problem that affects the daily life of the patients. Our results, defining the somatosensory phenotype, can improve the understanding of the pathophysiological mechanisms useful for future studies in the tailored treatment of prevention of chemotherapy-induced peripheral neuropathy and pain.

AB - Objective: To determine symptoms and characteristics of chronic sensory neuropathy in patients treated with oxaliplatin and docetaxel, including patterns of somatosensory abnormalities, pain descriptors, and psychological functioning.Design: A retrospective cross-sectional study.Setting: A chronic pain research center.Subjects: Thirty-eight patients with chronic peripheral pain and/or dysesthesia following chemotherapy.Methods:  Sensory profiles, psychological functioning, and quality of life were assessed using standardized questionnaires. In addition, standardized quantitative sensory testing and nerve conduction studies were carried out.Results: The sensory profiles and clinical symptoms were very similar in the two groups. Pricking, numbness, and burning were common descriptors in both groups, and the predominant finding was sensory loss to A beta-mediated sensory modalities with decreased mechanical and vibration detection thresholds. A high frequency of abnormalities in thermal sensory limen and the presence of paradoxical heat sensation seem to be sensitive markers of small fiber loss. Both groups had mainly sensory, axonal large fiber or mixed fiber polyneuropathy, which tended to be most severe in the oxaliplatin group.Conclusions: Both oxaliplatin-induced and docetaxel-induced polyneuropathies represent a significant problem that affects the daily life of the patients. Our results, defining the somatosensory phenotype, can improve the understanding of the pathophysiological mechanisms useful for future studies in the tailored treatment of prevention of chemotherapy-induced peripheral neuropathy and pain.

KW - Journal Article

U2 - 10.1093/pm/pnx231

DO - 10.1093/pm/pnx231

M3 - Journal article

C2 - 29036361

VL - 19

SP - 1813

EP - 1824

JO - Pain Medicine

JF - Pain Medicine

SN - 1526-2375

IS - 9

ER -